Cargando…
The temptation of anticoagulant therapy after transcatheter aortic valve implantation
The choice of the best antithrombotic strategy after transcatheter aortic valve implantation (TAVI) must be based on the careful balance between the ischaemic risk and the bleeding risk and on the evaluation of some concomitant conditions, such as atrial fibrillation or coronary artery disease which...
Autores principales: | Gatto, Laura, Scalia, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10120956/ https://www.ncbi.nlm.nih.gov/pubmed/37091637 http://dx.doi.org/10.1093/eurheartjsupp/suad081 |
Ejemplares similares
-
The new in anticoagulation: factor XI inhibitors
por: Muscente, Francesca, et al.
Publicado: (2023) -
Challenges in cardiology: diagnosis of native and prosthetic valve endocarditis
por: Pepi, Mauro, et al.
Publicado: (2023) -
Transcatheter mitral valve replacement: there is still work to be done
por: Bartorelli, Antonio L, et al.
Publicado: (2022) -
Treatment of multiple valve disease: surgery, structural intervention, or both?
por: Berti, Sergio, et al.
Publicado: (2023) -
Heart failure therapy: the fifth card
por: Balestrieri, Giulio, et al.
Publicado: (2023)